Global Mutational Analysis Market, By Type (Missense Mutation, Nonsense Mutation, Insertion, Deletion, Duplication, Frame Shift Mutation and Repeat Expansion), Product (Enzyme and Substrate), Technique (Denaturing Gradient Gel Electrophoresis (DGGE), Constant Denaturing Gel Electrophoresis (CDGE), Temporal Temperature Gradient Gel Electrophoresis (TTGE), Single- Strand Conformation Polymorphism (SSCP), Protein Truncation Test (PTT) and High Resolution Melt), End User (Academic Research Institutes, Contract Research Organization and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Mutational Analysis Market
Data Bridge Market Research analyses that the mutational analysis market will exhibit a CAGR of around 12.10% for the forecast period of 2021-2028. Overall growth in the genomics support in advance medicines, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of mutational analysis market.
Mutational analysis is a branch of genomics analysis wherein the sequence of DNA is changed owing to some internal and external factors. Mutational analysis is a reliable assay development which is used as mutation detection of next generation sequencing.
Upsurge in the prevalence of new-born genetic sequencing programs globally are the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements in the clinical next-generation sequencing (NSG) testing coupled with growth of the genomics industry is another market growth determinant. Rising research and development proficiencies, surge in the advancements in non-invasive cancer screening techniques and increasing support by the government to the genomics industry will further generate lucrative market growth opportunities.
However, high costs associated with equipment will derail the market growth rate. Dearth of skilled professionals and medical expertise will further pose challenges for the market. Also, lack of awareness in the backward and underdeveloped economies will also hamper the market growth rate.
This mutational analysis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on mutational analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Mutational Analysis Market Scope and Market Size
The mutational analysis market is segmented on the basis of type, product, technique and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- The global mutational analysis market is segmented on the basis of type into missense mutation, nonsense mutation, insertion, deletion, duplication, frame shift mutation and repeat expansion.
- On the basis of product, the mutational analysis market is segmented into enzyme and substrate.
- On the basis of technique, the mutational analysis market is segmented into denaturing gradient gel electrophoresis (DGGE), constant denaturing gel electrophoresis (CDGE), temporal temperature gradient gel electrophoresis (TTGE), single- strand conformation polymorphism (SSCP), protein truncation test (PTT) and high resolution melt.
- On the basis of end user, the mutational analysis market is segmented into academic research institutes, contract research organization and others.
Mutational Analysis Market Country Level Analysis
The mutational analysis market is analysed and market size insights and trends are provided by country, type, product, technique and end user as referenced above.
The countries covered in the mutational analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the mutational analysis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing advanced healthcare technologies, supportive government policies for research and development proficiencies and growing prevalence of major players. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing genomics industry.
The country section of the mutational analysis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
The mutational analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for mutational analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the mutational analysis market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Mutational Analysis Market Share Analysis
The mutational analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to mutational analysis market.
The major players covered in the mutational analysis market report are Novartis AG, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies Inc, GENERAL ELECTRIC COMPANY, PerkinElmer, Inc., QIAGEN, Eurofins Scientific, Quest Diagnostics Incorporated., Novogene Corporation., Promega Corporation., Luminex Corporation, Takara Bio Inc., Danaher., BioIVT., Elevate Scientific., Oxford Gene Technology IP Limited and Pacific Biosciences of California, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-